IDH1 and central nervous system cancer: In addition, Dow et al. found that cancer cells (including the ones derived from gliomas) engineered to express mutant IDH1 showed increased sensitivity to vorinostat than the corresponding controls through the enhanced ability of this HDACi to suppress the homology-directed repair of DNA in IDH-mutant cells [33].